The Landmark Discovery of Reversal of Frailty and Organ Decline with FOXO4-DRI

The Landmark Discovery of Reversal of Frailty and Organ Decline with FOXO4-DRI

  • Journal Context: Cell | Identifiers: DOI: 10.1016/j.cell.2017.02.031 / PMID: 28340339

  • Principal Investigators: Baar, M. P., Brandt, R. M., de Keizer, P. L., et al. (Erasmus University Medical Center, Netherlands)

  • Methodology: Longitudinal evaluation of fast-aging (progeroid) and naturally aged murine models administered systemic injections of FOXO4-DRI ($5\text{ mg/kg}$). Researchers tracked tissue changes, behavioral metrics (running speed, grip strength), hair density, and blood markers of kidney filtration.

  • Key Findings: FOXO4-DRI treatment induced targeted apoptosis exclusively in senescent cell lines. This selective clearance resulted in profound physiological rejuvenation:

    • Physical Fitness Restoration: Aged models demonstrated a massive recovery in physical endurance, significantly increasing voluntary wheel-running distance and maximum grip strength.

    • Structural Renovation: Fast-aging models experienced a complete restoration of fur density, reversing age-driven alopecia.

    • Organ Function Salvage: In both accelerated and natural aging lines, the peptide cleared senescent renal tubular cells, dropping plasma urea levels and reversing chronic renal filtration decline.

View study

Share

WhatsApp usChat with our team